Median overall survival in different types of cancer-related pericardial effusions
| Authors | Study period | Lung (months) | Median overall survival | |
| Breast (months) | Haematological (months) | |||
| Çelik et al 3 | 1985–2012 1999–2012 | 2.6 | 11 | 10 |
| Wagner et al 10 | 2004–2009 | 5 | 5 | 36 |
| Numico et al 11 | 2009–2015 | 1.4 | 19 | NR |
| Gornik et al 13 | 1999–2003 | 2.8 | 10.8 | 11.4 |
| Kim et al 16 | 2001–2007 | ADC-L: 6.8 SQ-L: 1.9 | 16.5 | NR |
| El Haddad et al 5 | 2009–2014 | Total: 3.2 LC with malignant PE: 1.7 LC with non-malignant PE: 9.6 | 8–10 | NR |
| Sampat et al 18 | 2003–2008 | – | – | 15 |
ADC-L, adenocarcinoma of the lung; LC, lung cancer; NR, not reported; PE, pericardial effusion; SQ-L, squamous cell carcinoma of the lung.